CareFusion 303, Inc. recalls Alaris Syringe Module Model 8110 - Product Usage: is intended to provide trained healthcare caregivers a way to automate

Recalled August 26, 2020 · FDA recall Z-2823-2020 · CareFusion 303

Hazard

LED display, which provides infusion or patient monitoring values, on the module may have segments that appear dim. · FDA Class II

Units

130612

Sold at

Worldwide distribution - U.S. Nationwide distribution including in the states of CO, FL, SC, NY, CA, NC, TX, IL, PA, AZ, LA, IN, MA, MO, AR, WI, HI, OR, OH, NJ, TN, NE, WA, KS, MI, MD, WV, KY, UT, MN, IA, GA, AL, DE, AK, VA, OK, NM, CT, SD, NV, ID, MT, ME, VT, MS, WY, NH, MP, DC, ND, GU, PR, AS, RI and the countries of TR, QA, CA, AE, KW, MX, GI, IL, SA, CH, NL, BE, TW, ZA, PH, CN, AU, IN, FR, MY, NZ, GB, KR, PK, DE, SG, JP, CU, IT, BH.

Description

LED display, which provides infusion or patient monitoring values, on the module may have segments that appear dim.

Product

Alaris Syringe Module Model 8110 - Product Usage: is intended to provide trained healthcare caregivers a way to automate the programming of infusion parameters, thereby decreasing the amount of manual steps necessary to enter infusion data.

Manufacturer(s)

CareFusion 303, Inc.

Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →